Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
February 7, 2015
[Systemic treatment of melanoma brain metastases]
É Le Rhun, C Mateus, L Mortier, et al.
The British Journal of Dermatology
|
May 14, 2015
Paradoxical simultaneous regression and progression of lesions in a phase II study of everolimus in classic Kaposi sarcoma
S Mourah, R Porcher, M Battistella, et al.
Annales De Dermatologie Et De Venereologie
|
July 2, 2016
[Items that justify a day-care hospital stay for the management of skin cancer. Guidelines from the Oncodermatology Group of the Société Française de Dermatologie]
L Mortier, P Saiag, L Thomas, et al.
The British Journal of Dermatology
|
April 20, 2012
Pre- vs. post-pubertal onset of vitiligo: multivariate analysis indicates atopic diathesis association in pre-pubertal onset vitiligo
K Ezzedine, A Diallo, C Léauté-Labrèze, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 26, 2017
French updated recommendations in Stage I to III melanoma treatment and management
B Guillot, S Dalac, M G Denis, et al.
Annales De Dermatologie Et De Venereologie
|
August 17, 2016
[Update to the recommendations for management of melanoma stages I to III]
B Guillot, S Dalac, M G Denis, et al.
Annales De Dermatologie Et De Venereologie
|
October 5, 2019
[Creation, implementation and objectives of CARADERM, a national network for rare skin carcinomas - Adnexal neoplasm part]
A Seris, M Battistella, M Beylot-Barry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 11, 2014
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial
S Leyvraz, S Piperno-Neumann, S Suciu, et al.
British Journal of Cancer
|
July 14, 2011
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies
T Eisen, R Marais, A Affolter, et al.
Cancer Immunology, Immunotherapy : CII
|
April 17, 2023
Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas
E Toulemonde, S Chevret, M Battistella, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
February 7, 2015
[Systemic treatment of melanoma brain metastases]
É Le Rhun, C Mateus, L Mortier, et al.
The British Journal of Dermatology
|
May 14, 2015
Paradoxical simultaneous regression and progression of lesions in a phase II study of everolimus in classic Kaposi sarcoma
S Mourah, R Porcher, M Battistella, et al.
Annales De Dermatologie Et De Venereologie
|
July 2, 2016
[Items that justify a day-care hospital stay for the management of skin cancer. Guidelines from the Oncodermatology Group of the Société Française de Dermatologie]
L Mortier, P Saiag, L Thomas, et al.
The British Journal of Dermatology
|
April 20, 2012
Pre- vs. post-pubertal onset of vitiligo: multivariate analysis indicates atopic diathesis association in pre-pubertal onset vitiligo
K Ezzedine, A Diallo, C Léauté-Labrèze, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 26, 2017
French updated recommendations in Stage I to III melanoma treatment and management
B Guillot, S Dalac, M G Denis, et al.
Annales De Dermatologie Et De Venereologie
|
August 17, 2016
[Update to the recommendations for management of melanoma stages I to III]
B Guillot, S Dalac, M G Denis, et al.
Annales De Dermatologie Et De Venereologie
|
October 5, 2019
[Creation, implementation and objectives of CARADERM, a national network for rare skin carcinomas - Adnexal neoplasm part]
A Seris, M Battistella, M Beylot-Barry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 11, 2014
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial
S Leyvraz, S Piperno-Neumann, S Suciu, et al.
British Journal of Cancer
|
July 14, 2011
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies
T Eisen, R Marais, A Affolter, et al.
Cancer Immunology, Immunotherapy : CII
|
April 17, 2023
Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas
E Toulemonde, S Chevret, M Battistella, et al.
Page
of 6